Expanding Clinical Trials
Although CBD has already disrupted the medical scene, most of its other possible applications remain under investigation, especially now that the FDA approved Epidiolex as an epilepsy treatment. Clinical trials are being done to inform researchers about the effects of CBD on:
On-going pain and inflammation.
Anxiety and mood disorders.
Alzheimer and Parkinson neurodegenerative diseases.
Autoimmune disorders such as multiple sclerosis and rheumatoid arthritis.
Substance-use disorders and addiction recovery.
The objectives of these trials are not only to find out whether CBD is effective or not, but also to identify the most valid doses, delivery modes and long-term safety profiles.
Possible Pharmaceutical Uses.
In addition to the supplements and wellness products, the use of CBD is also under investigation in pharmaceutical development. Researchers are working on the ability of CBD to be used with other cannabinoids or terpenes or even synthetic substances to be used in specific therapies. For instance:
Drugs based on CBD to treat chronic pain.
Anxiety or depression combination therapy.
Neuroprotective drugs meant to delay the disease.
This drug appeal is an indication that CBD does not just remain a wellness craze in nature but may end up being a more formalized part of evidence-based medicine.
One can look forward to challenges ahead in science.
Even in the wake of the progress, there are a number of obstacles that slow down the research of CBD:
Barriers of regulation: Cannabis-related research is subject to tough approval in most countries.
Financial constraints: There are limited grants to carry out research on cannabis as compared to other medical research areas.
Product inconsistency: Due to the variability of the formulation of the product, it becomes hard to carry out the standardized, repeatable studies.
These barriers will have to be overcome to further our knowledge of the actual potential of CBD.